Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Finance and funding news

Show

From To
US: Study shows direct link between state spending habits and AIDS deaths

American states with higher spending on social services and public health -- such as education and income support -- per person living in poverty (according to the federal poverty threshold) had significantly lower HIV/AIDS case rates and fewer AIDS deaths.

Published
04 February 2016
From
Eurekalert Inf Dis
Merck Throws a Wrench in Drug Pricing

Volume may help Merck make up what it loses on price. AbbVie and Gilead's drugs are priced so high that many governments and insurers will only pay for them for patients that have severe liver scarring, given HCV's slow progression. Zepatier is priced at a point that could make it affordable to treat a much larger population at earlier stages of the disease.

Published
01 February 2016
From
Bloomberg
Only 3 Presidential Candidates Share How They Will Address HIV

Only 3 out of the 16 candidates running for president answered GMHC's survey on how they plan to govern on issues concerning HIV.

Published
01 February 2016
From
HIVPlus
California Doles Out Millions to Insurers for Hepatitis C Drugs

In an unusual funding arrangement, California is paying private health plans hundreds of millions of dollars in supplemental payments to cover the high price of hepatitis C drugs for patients in Medi-Cal managed care plans.

Published
29 January 2016
From
KQED News
London sexual health clinics step up their support for people buying PrEP online

Several large sexual health clinics in London and Brighton have responded to the growing numbers of people importing PrEP medications from overseas by offering free safety monitoring

Published
29 January 2016
By
Roger Pebody
Massachusetts official challenges Gilead's hepatitis C drug prices

Massachusetts' attorney general is studying whether prices of Gilead Sciences' blockbuster treatments for hepatitis C violate state law, according to a letter the prosecutor sent to the California-based drugmaker.

Published
28 January 2016
From
Reuters
About that latest big Gates Foundation bet for HIV prevention

It isn’t too out of the ordinary for Gates Foundation grant awards to soar into the eight- and even nine-figure range. So, its $20 million grant to Moderna Therapeutics to support its continuing development of a novel but promising HIV prevention therapy isn’t particularly extraordinary. But what is unusual...is that the total potential commitment from the foundation could reach upwards of $100 million—around 70 percent of the Gates Foundation’s HIV/AIDS grants for all of last year.

Published
27 January 2016
From
Inside Philanthropy
Infected blood: reform of financial and other support

Seeks views on the reforms to the support for those affected by hepatitis C or HIV from historic NHS blood treatments.

Published
26 January 2016
From
Department of Health
UK: Closure of PACE, the LGBT+ mental health charity

PACE, the LGBT+ mental health charity, will close at the end of January 2016 due to lack of funding. Founded in 1985 PACE has provided support services for the LGBT+ community for over 30 years delivering counselling, advocacy, training, youth work, research and mental health support services.

Published
26 January 2016
From
PACE
Reaction to The Global Fund’s Fifth Replenishment target muted

Reaction to the size of The Global Fund’s 5th Replenishment target has been somewhat muted so far, despite the fact that at $13 billion, it is $2 billion lower than the target for the last replenishment, and despite the global push to ending the epidemics by 2030 as set out in the Sustainable Development Goals.

Published
24 January 2016
From
Global Fund Observer
← First12345...83Next →

Filter by country